1. Home
  2. IDYA vs HI Comparison

IDYA vs HI Comparison

Compare IDYA & HI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • HI
  • Stock Information
  • Founded
  • IDYA 2015
  • HI 2007
  • Country
  • IDYA United States
  • HI United States
  • Employees
  • IDYA N/A
  • HI N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • HI Miscellaneous manufacturing industries
  • Sector
  • IDYA Health Care
  • HI Consumer Discretionary
  • Exchange
  • IDYA Nasdaq
  • HI Nasdaq
  • Market Cap
  • IDYA 2.2B
  • HI 2.4B
  • IPO Year
  • IDYA 2019
  • HI N/A
  • Fundamental
  • Price
  • IDYA $22.18
  • HI $33.94
  • Analyst Decision
  • IDYA Strong Buy
  • HI Buy
  • Analyst Count
  • IDYA 13
  • HI 2
  • Target Price
  • IDYA $53.67
  • HI $36.50
  • AVG Volume (30 Days)
  • IDYA 890.0K
  • HI 426.3K
  • Earning Date
  • IDYA 02-18-2025
  • HI 02-03-2025
  • Dividend Yield
  • IDYA N/A
  • HI 2.63%
  • EPS Growth
  • IDYA N/A
  • HI N/A
  • EPS
  • IDYA N/A
  • HI N/A
  • Revenue
  • IDYA $3,922,000.00
  • HI $3,182,800,000.00
  • Revenue This Year
  • IDYA N/A
  • HI N/A
  • Revenue Next Year
  • IDYA $251.89
  • HI $4.10
  • P/E Ratio
  • IDYA N/A
  • HI N/A
  • Revenue Growth
  • IDYA N/A
  • HI 12.63
  • 52 Week Low
  • IDYA $22.10
  • HI $25.11
  • 52 Week High
  • IDYA $47.74
  • HI $50.58
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 31.90
  • HI 67.20
  • Support Level
  • IDYA $22.17
  • HI $30.25
  • Resistance Level
  • IDYA $24.06
  • HI $31.79
  • Average True Range (ATR)
  • IDYA 1.06
  • HI 0.83
  • MACD
  • IDYA -0.22
  • HI 0.38
  • Stochastic Oscillator
  • IDYA 1.84
  • HI 91.38

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

About HI Hillenbrand Inc

Hillenbrand Inc is a U.S.-based company that operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment. The Molding Technology Solutions segment offers engineered and customized systems in plastic technology and processing. It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.

Share on Social Networks: